c-ray
06-11-2007, 08:21 PM
Researchers at the Orlando Immunology Center in Florida
investigated the long-term effects of THC (dronabinol) on 117
patients with HIV/AIDS, who lost weight. Subjects who
received dronabinol for 3 to 12 months were included in a
retrospective analysis. THC was shown to improve appetite and
weight and to reduce nausea.
63 per cent of patients maintained or gained weight. In subjects
receiving THC for 1 year, the mean weight gain was about 1700
grams. The percentage of patients experiencing loss of appetite
decreased significantly from 71 per cent to 26 per cent at 1
month after start of the therapy and continued to decline
throughout the trial. The percentage of patients experiencing
nausea (38 per cent) decreased consistently from week 2 on.
(Source: Dejesus E, Rodwick BM, Bowers D, Cohen CJ,
Pearce D. Use of dronabinol improves appetite and reverses
weight loss in HIV/AIDS-infected patients. J Int Assoc
Physicians AIDS Care 2007;6(2):95-100.)
investigated the long-term effects of THC (dronabinol) on 117
patients with HIV/AIDS, who lost weight. Subjects who
received dronabinol for 3 to 12 months were included in a
retrospective analysis. THC was shown to improve appetite and
weight and to reduce nausea.
63 per cent of patients maintained or gained weight. In subjects
receiving THC for 1 year, the mean weight gain was about 1700
grams. The percentage of patients experiencing loss of appetite
decreased significantly from 71 per cent to 26 per cent at 1
month after start of the therapy and continued to decline
throughout the trial. The percentage of patients experiencing
nausea (38 per cent) decreased consistently from week 2 on.
(Source: Dejesus E, Rodwick BM, Bowers D, Cohen CJ,
Pearce D. Use of dronabinol improves appetite and reverses
weight loss in HIV/AIDS-infected patients. J Int Assoc
Physicians AIDS Care 2007;6(2):95-100.)